Published in Oncogene on August 31, 2009
Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness. Nat Struct Mol Biol (2012) 1.67
DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions. Nature (2015) 1.60
RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum Mol Genet (2012) 1.51
Comparative structural analysis of human DEAD-box RNA helicases. PLoS One (2010) 1.21
Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am J Transl Res (2010) 1.15
DEAD box RNA helicase functions in cancer. RNA Biol (2013) 1.06
DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov (2012) 1.02
RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells. Mol Cell Proteomics (2011) 1.01
Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev (2012) 1.01
Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. J Biol Chem (2010) 1.00
Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J Biol Chem (2010) 0.99
The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage. Oncogene (2012) 0.97
Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proc Natl Acad Sci U S A (2014) 0.96
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-κB transcription factor p50. Neuro Oncol (2012) 0.92
Signaling-mediated regulation of MicroRNA processing. Cancer Res (2015) 0.87
P68 RNA helicase as a molecular target for cancer therapy. J Exp Clin Cancer Res (2014) 0.85
p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer. PLoS One (2013) 0.85
Retracted Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci (2014) 0.84
Transcription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigm. Mol Med (2011) 0.83
The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Res (2013) 0.81
The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers. Cell Cycle (2014) 0.79
Elevated DDX21 regulates c-Jun activity and rRNA processing in human breast cancers. Breast Cancer Res (2014) 0.79
An evolutionarily conserved, alternatively spliced, intron in the p68/DDX5 DEAD-box RNA helicase gene encodes a novel miRNA. RNA (2011) 0.79
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. Br J Cancer (2014) 0.79
The RNA helicase Ddx5/p68 binds to hUpf3 and enhances NMD of Ddx17/p72 and Smg5 mRNA. Nucleic Acids Res (2013) 0.79
Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5. Cell Rep (2014) 0.78
Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells. Oncogene (2014) 0.76
DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway. Sci Rep (2017) 0.75
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell (2000) 11.10
CBP/p300 in cell growth, transformation, and development. Genes Dev (2000) 10.76
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia (2007) 10.74
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell (2003) 10.42
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
Birth of the D-E-A-D box. Nature (1989) 7.02
DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell (2001) 4.72
Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer (2002) 4.57
Retracted DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol (2007) 4.45
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst (2003) 4.45
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J (1996) 3.53
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J (1989) 3.23
DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res (2006) 2.87
Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev (1994) 2.83
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature (2008) 2.51
Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J Biol Chem (1994) 2.30
Retracted Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol Cell Biol (1999) 2.25
Retracted A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J (2001) 2.21
The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J (2005) 2.12
Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J (1993) 1.99
Estrogen receptor interaction with co-activators and co-repressors. Steroids (2000) 1.91
RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell (1999) 1.85
The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev Cell (2006) 1.78
Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell (2000) 1.77
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res (2008) 1.58
Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene (2003) 1.32
The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol (2004) 1.31
Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer disease-free and overall survival in breast cancer patients. Clin Cancer Res (2007) 1.29
Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity. J Biol Chem (2005) 1.25
Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J Pathol (1998) 1.23
The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res (2003) 1.22
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. Endocr Relat Cancer (2006) 1.20
p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. J Cell Biochem (2008) 1.16
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. J Mol Endocrinol (2008) 1.15
SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene (2007) 1.14
Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor. Mol Endocrinol (2007) 1.10
The mRNA of DEAD box protein p72 is alternatively translated into an 82-kDa RNA helicase. J Biol Chem (2001) 1.06
Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Proc Natl Acad Sci U S A (1997) 1.02
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. Nucleic Acids Res (2006) 1.02
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Res (2001) 0.97
Fulvestrant ('Faslodex')--a new treatment option for patients progressing on prior endocrine therapy. Endocr Relat Cancer (2002) 0.93
Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF. J Cell Biochem (2007) 0.92
The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol (2001) 6.10
Wind-driven upwelling in the Southern Ocean and the deglacial rise in atmospheric CO2. Science (2009) 5.36
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA (2001) 4.38
Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol (2001) 4.38
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med (1999) 3.98
Construction and characterization of a bacterial artificial chromosome library of Sorghum bicolor. Nucleic Acids Res (1994) 3.94
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem (2001) 3.86
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
DNA finger printing by oligonucleotide probes specific for simple repeats. Hum Genet (1986) 3.41
Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallogr D Biol Crystallogr (1998) 3.35
HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A (1998) 3.35
Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes Dev (1999) 3.05
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82
Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int (2006) 2.72
The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections. Br J Cancer (1980) 2.50
Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg (2010) 2.48
Rice (Oryza sativa) centromeric regions consist of complex DNA. Proc Natl Acad Sci U S A (1998) 2.42
Missed appointments in general practice: retrospective data analysis from four practices. Br J Gen Pract (2001) 2.33
The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol (Phila) (2014) 2.31
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
Orcein as a mucin stain for gastrointestinal tissue sections. J Clin Pathol (1981) 2.28
Src tyrosine kinase is a novel direct effector of G proteins. Cell (2000) 2.26
Template engineering of Co-doped BaFe2As2 single-crystal thin films. Nat Mater (2010) 2.22
Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci U S A (2000) 2.22
Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet (2001) 2.22
Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis (1993) 2.19
Nodeless superconducting gap in A(x)Fe2Se2 (A=K,Cs) revealed by angle-resolved photoemission spectroscopy. Nat Mater (2011) 2.16
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res (2001) 2.15
Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer (1992) 2.10
Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet (1987) 2.09
Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07
The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res (1998) 2.06
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
DbpA: a DEAD box protein specifically activated by 23s rRNA. EMBO J (1993) 2.04
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res (1987) 2.03
Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol (2001) 2.01
Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A (2000) 1.96
Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88
The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect (1998) 1.86
Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res (1994) 1.84
Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J Immunol (2001) 1.84
Toward a cytological characterization of the rice genome. Genome Res (2001) 1.83
High intergrain critical current density in fine-grain (Ba0.6K0.4)Fe2As2 wires and bulks. Nat Mater (2012) 1.83
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy (1999) 1.83
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
Retrotransposon-related DNA sequences in the centromeres of grass chromosomes. Genetics (1998) 1.80
Survey of treatment of primary breast cancer in Great Britain. Br Med J (Clin Res Ed) (1985) 1.80
Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J Biol Chem (1998) 1.80
Genetic recombination can generate altered restriction specificity. Proc Natl Acad Sci U S A (1984) 1.79
Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia (2000) 1.79
Protein kinase A antagonizes Hedgehog signaling by regulating both the activator and repressor forms of Cubitus interruptus. Genes Dev (1999) 1.79
Three-dimensional atomic-scale structure of size-selected gold nanoclusters. Nature (2008) 1.77
Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell (2000) 1.77
RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant (2013) 1.75
Interactions with Costal2 and suppressor of fused regulate nuclear translocation and activity of cubitus interruptus. Genes Dev (2000) 1.75
Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat (2005) 1.74
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics (2002) 1.73
Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73
Diagnosing breast carcinoma in young women. BMJ (1991) 1.71
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res (1992) 1.68
Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol Diagn (2001) 1.67
Proteinuria in obstructive sleep apnea. Kidney Int (2001) 1.66
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A (1999) 1.66
Strongly linked current flow in polycrystalline forms of the superconductor MgB2. Nature (2001) 1.64
Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol (1999) 1.60
Study of toxin production by isolates of Stachybotrys chartarum and Memnoniella echinata isolated during a study of pulmonary hemosiderosis in infants. Appl Environ Microbiol (1998) 1.59
Application of fiber-FISH in physical mapping of Arabidopsis thaliana. Genome (1998) 1.58
Two DNA recognition domains of the specificity polypeptides of a family of type I restriction enzymes. Proc Natl Acad Sci U S A (1986) 1.56
Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A (2001) 1.55
Effectiveness of fast-track rehabilitation vs conventional care in laparoscopic colorectal resection for elderly patients: a randomized trial. Colorectal Dis (2012) 1.55
Ultrastructural and functional characteristics of blast injury-induced neurotrauma. J Trauma (2001) 1.54
Definition of the p53 functional domains necessary for inducing apoptosis. J Biol Chem (2000) 1.52
Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene (2001) 1.51
Characterization of surface properties of Vibrio cholerae. Infect Immun (1983) 1.50
Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50
A stroke unit in a district general hospital: the Greenwich experience. Br Med J (1979) 1.50
Microincineration, electron microscopy, and electron diffraction of calcium phosphate-loaded mitochondria. J Cell Biol (1968) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48
Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant (2009) 1.48
Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants. J Hosp Infect (2011) 1.48
Complex mtDNA constitutes an approximate 620-kb insertion on Arabidopsis thaliana chromosome 2: implication of potential sequencing errors caused by large-unit repeats. Proc Natl Acad Sci U S A (2001) 1.47
Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C. Diabetes Technol Ther (2003) 1.46
Multisite phosphotyping of the ErbB-2 oncoprotein in human breast cancer. Mol Diagn (2001) 1.44
EcoA and EcoE: alternatives to the EcoK family of type I restriction and modification systems of Escherichia coli. J Mol Biol (1985) 1.44
Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 1.43
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem (1997) 1.42
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42
Estrogen receptor beta in breast cancer. Endocr Relat Cancer (2002) 1.41
Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen (2007) 1.41